Joseph S. Ainscough
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Joseph S. Ainscough has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Ian Kimber
Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom
4 shared publicationsG. Frank Gerberick
Procter & Gamble Co., Cincinnati, Ohio 45253
3 shared publicationsRebecca J. Dearman
Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom
3 shared publications- David Brough
Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester, UK
2 shared publications Ade Alase
Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), University of Leeds, Leeds LS7 4SA, United Kingdom
1 shared publication- Alexei Verkhratsky
Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
1 shared publication
Latest Publications
- 13 March 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (13) , E2748-E2757
Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ
Significance: IL-36γ is a potent cytokine that drives and orchestrates inflammation. It is strongly expressed at barrier tissues such as the skin and thus is particularly relevant to inflammatory diseases that affect these tissues, including psoriasis. IL-36γ is expressed as an inactive precursor that requires precise N-terminal truncation for activation. In these investigations, we demonstrate that cathepsin S is the major IL-36γ–activating protease expressed by barrier tissues. Moreover, we show that both cathepsin S and IL-36γ are strongly up-regulated in psoriatic inflammation. These findings are important as they both identify the mechanism of IL-36γ activation and highlight that this mechanism may play a central role in the development of psoriatic inflammation.
- 13 March 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (13) , E2748-E2757
Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ
Significance: IL-36γ is a potent cytokine that drives and orchestrates inflammation. It is strongly expressed at barrier tissues such as the skin and thus is particularly relevant to inflammatory diseases that affect these tissues, including psoriasis. IL-36γ is expressed as an inactive precursor that requires precise N-terminal truncation for activation. In these investigations, we demonstrate that cathepsin S is the major IL-36γ–activating protease expressed by barrier tissues. Moreover, we show that both cathepsin S and IL-36γ are strongly up-regulated in psoriatic inflammation. These findings are important as they both identify the mechanism of IL-36γ activation and highlight that this mechanism may play a central role in the development of psoriatic inflammation.
- Open Access
- 1 December 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (52) , 31151-31161
Interleukin-1β Processing Is Dependent on a Calcium-mediated Interaction with Calmodulin
- 1 December 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (52) , 31151-31161
Open AccessInterleukin-1β Processing Is Dependent on a Calcium-mediated Interaction with Calmodulin
- Open Access
P2X7R activation drives distinct IL-1 responses in dendritic cells compared to macrophages
- Open Access
- 1 December 2014
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (51) , 35582-35592
Dendritic Cell IL-1α and IL-1β Are Polyubiquitinated and Degraded by the Proteasome
- 1 December 2014
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (51) , 35582-35592
Open AccessDendritic Cell IL-1α and IL-1β Are Polyubiquitinated and Degraded by the Proteasome
- 7 September 2012
- Published by Taylor & Francis in Journal of Immunotoxicology
- Vol. 10 (3) , 223-234
Danger, intracellular signaling, and the orchestration of dendritic cell function in skin sensitization
Allergic contact dermatitis is an important occupational and environmental disease caused by topical exposure to chemical allergens. An area of considerable interest and, in the context of hazard identification and characterization, an area of great importance is developing an understanding of the characteristics that confer on chemicals the ability to cause skin sensitization. For the successful acquisition of skin sensitization, it is necessary that a chemical must gain access to the viable epidermis, form stable immunogenic associations with host proteins, and provide the necessary stimuli for the activation, mobilization, and maturation of skin dendritic cells (DC). It is the last of these properties that is the subject of this article. The purpose here is to review the mechanisms through which skin sensitizers provide the triggers necessary for engagement of cutaneous DC. Of particular interest are the nature and function of danger signals elicited by skin sensitizing chemicals. Among the pathways considered here are those involving Toll-like receptors, C-type lectin receptors, neuropeptide receptors, prostanoid receptors, and the inflammasome. Collectively, danger signals in the skin provide a bridge between the innate and adaptive immune systems and are of pivotal importance for the initiation of cutaneous immune responses, including those to chemical allergens that result in skin sensitization.
- 7 September 2012
- Published by Taylor & Francis in Journal of Immunotoxicology
- Vol. 10 (3) , 223-234
Danger, intracellular signaling, and the orchestration of dendritic cell function in skin sensitization
Allergic contact dermatitis is an important occupational and environmental disease caused by topical exposure to chemical allergens. An area of considerable interest and, in the context of hazard identification and characterization, an area of great importance is developing an understanding of the characteristics that confer on chemicals the ability to cause skin sensitization. For the successful acquisition of skin sensitization, it is necessary that a chemical must gain access to the viable epidermis, form stable immunogenic associations with host proteins, and provide the necessary stimuli for the activation, mobilization, and maturation of skin dendritic cells (DC). It is the last of these properties that is the subject of this article. The purpose here is to review the mechanisms through which skin sensitizers provide the triggers necessary for engagement of cutaneous DC. Of particular interest are the nature and function of danger signals elicited by skin sensitizing chemicals. Among the pathways considered here are those involving Toll-like receptors, C-type lectin receptors, neuropeptide receptors, prostanoid receptors, and the inflammasome. Collectively, danger signals in the skin provide a bridge between the innate and adaptive immune systems and are of pivotal importance for the initiation of cutaneous immune responses, including those to chemical allergens that result in skin sensitization.